B Cell–Intrinsic IDO1 Regulates Humoral Immunity to T Cell–Independent Antigens

Humoral responses to nonproteinaceous Ags (i.e., T cell independent [TI]) are a key component of the early response to bacterial and viral infection and a critical driver of systemic autoimmunity. However, mechanisms that regulate TI humoral immunity are poorly defined. In this study, we report that B cell–intrinsic induction of the tryptophan-catabolizing enzyme IDO1 is a key mechanism limiting TI Ab responses. When Ido1−/− mice were immunized with TI Ags, there was a significant increase in Ab titers and formation of extrafollicular Ab-secreting cells compared with controls. This effect was specific to TI Ags, as Ido1 disruption did not affect Ig production after immunization with protein Ags. The effect of IDO1 abrogation was confined to the B cell compartment, as adoptive transfer of Ido1−/− B cells to B cell–deficient mice was sufficient to replicate increased TI responses observed in Ido1−/− mice. Moreover, in vitro activation with TLR ligands or BCR crosslinking rapidly induced Ido1 expression and activity in purified B cells, and Ido1−/− B cells displayed enhanced proliferation and cell survival associated with increased Ig and cytokine production compared with wild-type B cells. Thus, our results demonstrate a novel, B cell–intrinsic, role for IDO1 as a regulator of humoral immunity that has implications for both vaccine design and prevention of autoimmunity.

[1]  M. Geffard,et al.  Aryl hydrocarbon receptor control of a disease tolerance defence pathway , 2014, Nature.

[2]  G. Prendergast,et al.  IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation. , 2014, International immunology.

[3]  D. Munn,et al.  Marginal zone CD169+ macrophages coordinate apoptotic cell-driven cellular recruitment and tolerance , 2014, Proceedings of the National Academy of Sciences.

[4]  G. Prendergast,et al.  IDO2 Is a Critical Mediator of Autoantibody Production and Inflammatory Pathogenesis in a Mouse Model of Autoimmune Arthritis , 2014, The Journal of Immunology.

[5]  D. Munn,et al.  GCN2-Dependent Metabolic Stress Is Essential for Endotoxemic Cytokine Induction and Pathology , 2013, Molecular and Cellular Biology.

[6]  T. Manser,et al.  Cutting Edge: Macrophages Are Required for Localization of Antigen-Activated B Cells to the Follicular Perimeter and the Subsequent Germinal Center Response , 2013, The Journal of Immunology.

[7]  Irene Puga,et al.  Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes , 2013, Nature Reviews Immunology.

[8]  R. Horton,et al.  Visualization of splenic marginal zone B cell shuttling and follicular B cell egress , 2012, Nature.

[9]  G. Prendergast,et al.  Amino acid catabolism: a pivotal regulator of innate and adaptive immunity , 2012, Immunological reviews.

[10]  L. Mandik-Nayak,et al.  Addition of an indoleamine 2,3,-dioxygenase inhibitor to B cell-depletion therapy blocks autoreactive B cell activation and recurrence of arthritis in K/BxN mice. , 2012, Arthritis and rheumatism.

[11]  T. Tsubata,et al.  Apoptotic marginal zone deletion of anti-Sm/ribonucleoprotein B cells , 2012, Proceedings of the National Academy of Sciences.

[12]  C. Mauri,et al.  Immune regulatory function of B cells. , 2012, Annual review of immunology.

[13]  Rahul Shinde,et al.  Tolerance to apoptotic cells is regulated by indoleamine 2,3-dioxygenase , 2012, Proceedings of the National Academy of Sciences.

[14]  S. Serrano,et al.  B–helper neutrophils stimulate immunoglobulin diversification and production in the marginal zone of the spleen , 2011, Nature Immunology.

[15]  D. Leclerc,et al.  IDO expression by human B lymphocytes in response to T lymphocyte stimuli and TLR engagement is biologically inactive. , 2011, Molecular immunology.

[16]  L. Morel,et al.  Autoreactive marginal zone B cells enter the follicles and interact with CD4+ T cells in lupus-prone mice , 2011, BMC Immunology.

[17]  J. Fechner,et al.  An Interaction between Kynurenine and the Aryl Hydrocarbon Receptor Can Generate Regulatory T Cells , 2010, The Journal of Immunology.

[18]  M. Colonna,et al.  Type I IFN enhances follicular B cell contribution to the T cell–independent antibody response , 2010, The Journal of experimental medicine.

[19]  G. Prendergast,et al.  The Immunoregulatory Enzyme IDO Paradoxically Drives B Cell-Mediated Autoimmunity1 , 2009, The Journal of Immunology.

[20]  K. Rock,et al.  Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization , 2008, Nature Immunology.

[21]  G. Prendergast,et al.  Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan. , 2007, Cancer research.

[22]  D. Quiceno,et al.  L-arginine availability regulates T-lymphocyte cell-cycle progression. , 2007, Blood.

[23]  G. Widhopf,et al.  Alternative and classical NF-kappa B signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease. , 2006, Immunity.

[24]  T. Espevik,et al.  Toll-like receptors mediate proliferation and survival of multiple myeloma cells , 2006, Leukemia.

[25]  M. Nussenzweig,et al.  T-independent type II immune responses generate memory B cells , 2006, The Journal of experimental medicine.

[26]  B. Baban,et al.  GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. , 2005, Immunity.

[27]  R. Wek,et al.  Phosphorylation of the α-Subunit of the Eukaryotic Initiation Factor-2 (eIF2α) Reduces Protein Synthesis and Enhances Apoptosis in Response to Proteasome Inhibition* , 2005, Journal of Biological Chemistry.

[28]  K. Calame,et al.  Regulation of plasma-cell development , 2005, Nature Reviews Immunology.

[29]  B. Baban,et al.  Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. , 2004, The Journal of clinical investigation.

[30]  Shizuo Akira,et al.  TLR signaling pathways. , 2004, Seminars in immunology.

[31]  C. Gélinas,et al.  To be, or not to be: NF-κB is the answer – role of Rel/NF-κB in the regulation of apoptosis , 2003, Oncogene.

[32]  K. Shirey,et al.  Synergistic Transcriptional Activation of Indoleamine Dioxygenase by IFN-γ and Tumor Necrosis Factor-α , 2003 .

[33]  K. Toellner,et al.  Extrafollicular antibody responses , 2003, Immunological reviews.

[34]  K. Toellner,et al.  Recirculating and germinal center B cells differentiate into cells responsive to polysaccharide antigens , 2003, European journal of immunology.

[35]  B. Nardelli,et al.  DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL , 2002, Nature Immunology.

[36]  J. Kearney,et al.  Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. , 2001, Immunity.

[37]  J. Schlessinger,et al.  Absence of marginal zone B cells in Pyk-2–deficient mice defines their role in the humoral response , 2000, Nature Immunology.

[38]  K. Toellner,et al.  T‐independent type 2 antigens induce B cell proliferation in multiple splenic sites, but exponential growth is confined to extrafollicular foci , 1999, European journal of immunology.

[39]  G. Evan,et al.  Induction of apoptosis by the Bcl-2 homologue Bak , 1995, Nature.

[40]  G. Bishop,et al.  CpG motifs in bacterial DNA trigger direct B-cell activation , 1995, Nature.

[41]  G. Kelsoe,et al.  In situ studies of the primary immune response to (4-hydroxy-3- nitrophenyl)acetyl. I. The architecture and dynamics of responding cell populations , 1991, The Journal of experimental medicine.

[42]  V. Braun,et al.  The lipoprotein of the outer membrane of Escherichia coli: a B- lymphocyte mitogen , 1975, The Journal of experimental medicine.

[43]  T. Eleftheriadis,et al.  Suppression of humoral immune response to hepatitis B surface antigen vaccine in BALB/c mice by 1-methyl-tryptophan co-administration , 2011, Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences.

[44]  I. Maclennan,et al.  Germinal centres in T-cell-dependent antibody responses. , 1992, Immunology today.